Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)
Condition(s):Skin Ulcer Venous Stasis ChronicLast Updated:March 22, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Skin Ulcer Venous Stasis ChronicLast Updated:March 22, 2024Recruiting
Condition(s):Epidermolysis BullosaLast Updated:October 30, 2023Recruiting
Condition(s):Epidermolysis BullosaLast Updated:February 24, 2023Recruiting
Condition(s):Epidermal Necrolysis; Lyell Syndrome; Toxic Epidermal Necrolysis; Overlap Syndrome; Mesenchymal Stromal Cells; Adipose Derived Stromal CellsLast Updated:May 3, 2022Not yet recruiting
Condition(s):Systemic Sclerosis Pulmonary; Pulmonary Hypertension; Pulmonary FibrosisLast Updated:June 16, 2020Available
Condition(s):Epidermolysis Bullosa DystrophicaLast Updated:February 26, 2024Not yet recruiting
Condition(s):Recessive Dystrophic Epidermolysis BullosaLast Updated:March 3, 2017Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.